Featured Research

from universities, journals, and other organizations

Scientists Develop Prototype Drug To Prevent Osteoporosis Based On Cannabinoids Produced By Body

Date:
January 5, 2006
Source:
The Hebrew University of Jerusalem
Summary:
Substances produced in the body that act like those found in the cannabis plant help preserve bone density, according to researchers at the Hebrew University of Jerusalem. Based on this finding, a prototype for a new drug to prevent osteoporosis (loss of bone density) without any psychoactive side effects has already been developed.

Normal bone tissue with CB2 receptors is seen at left. At right is bone tissue in which CB2 is absent, showing serious bone density loss.
Credit: Image courtesy of The Hebrew University of Jerusalem

Substances produced in the body that act like those found in the cannabis plant help preserve bone density, according to researchers at the Hebrew University of Jerusalem. Based on this finding, a prototype for a new drug to prevent osteoporosis (loss of bone density) without any psychoactive side effects has already been developed.

Related Articles


An article describing this research appears this week in the prestigious American journal PNAS (Proceedings of the National Academy of Sciences of the U.S.A.). The researchers, from the Bone Laboratory of the Hebrew University, are headed by Prof. Itai Bab, working in cooperation with Prof. Esther Shohami of the Laboratory for the Study of Bain Trauma; Prof. Raphael Mechoulam of the Hebrew University School of Pharmacy; doctoral students Orr Ofek, Vardits Krem and Yossi Tam; and master's degree student Meirav Fogel.

Substances made in the body called endocannabinoids are composed mainly of fatty acids which were discovered during the last 15 years. (The fatty acid anandamid was discovered by Prof. Mechoulam in 1992.) These materials, which are produced mainly in the brain, are present also in the bone and other tissues and have similar effects to those of the active components in hashish and marijuana, produced from the cannabis plant.

These substances bind to and activate two receptors, CB1 and CB2. The first is found in the nervous system and is responsible for the psychoactive effects of the active components in the cannabis plant and endocannanoids. The second receptor is found in the immune system. It is not known to be involved with psychoactive responses, and there has been little information about its physiological function.

The Hebrew University researchers discovered a high level of CB2 receptors in bone, and that this is required in order to preserve normal bone density. Together with their colleagues at the University of Bonn, Germany, Prof. Andreas Zimmer and Dr. Malia Karasek, they studied the skeletons of genetically engineered mice lacking the CB2 receptor. As they aged, these CB2-deprived mice developed severe osteoporosis, similar to that which appears in humans. Osteoporosis is the most widespread degenerative disease in developed countries and can lead to multiple fractures, disability and complications, and even death.

The scientists' findings have thus assigned, for the first time, a physiological function to CB2 in preserving bone density and showed that it stimulates bone building and reduces bone loss. This indicates that substances that active the CB2 receptor can be used as basis for the development of drugs for osteoporosis patients. Indeed, the Hebrew University researchers have developed a new synthetic compound, HU-308, which activates CB2 and slows the development of osteoporosis in mice. This compound forms the basis for a cannabinoid-based, anti-osteoporotic type drug which has also been found to be free of any psychoactive side effects.

###

The Hebrew University research was conducted within the framework of a project directed at clarifying the connection between the brain, behavior and changes in skeletal structure. The research was funded by the Bikura (First) Program of the Israel Science Foundation, which supports pioneering, innovative, interdisciplinary projects. The research also received funding from the U.S. National Institutes of Health.


Story Source:

The above story is based on materials provided by The Hebrew University of Jerusalem. Note: Materials may be edited for content and length.


Cite This Page:

The Hebrew University of Jerusalem. "Scientists Develop Prototype Drug To Prevent Osteoporosis Based On Cannabinoids Produced By Body." ScienceDaily. ScienceDaily, 5 January 2006. <www.sciencedaily.com/releases/2006/01/060104232013.htm>.
The Hebrew University of Jerusalem. (2006, January 5). Scientists Develop Prototype Drug To Prevent Osteoporosis Based On Cannabinoids Produced By Body. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2006/01/060104232013.htm
The Hebrew University of Jerusalem. "Scientists Develop Prototype Drug To Prevent Osteoporosis Based On Cannabinoids Produced By Body." ScienceDaily. www.sciencedaily.com/releases/2006/01/060104232013.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins